Compare Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund
Tata India Pharma & Healthcare Fund
UTI Healthcare Fund
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.28
2.23
NAV
₹38.98
₹372.01
Fund Started
04 Dec 2015
01 Aug 2005
Fund Size
₹1455.16 Cr
₹1307.98 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year
7.50%
10.78%
3 Year
20.21%
24.11%
5 Year
13.12%
13.94%
Equity
97.42%
95.05%
Cash
2.58%
4.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.51% |
Max Healthcare Institute Ltd. | 5.68% |
Healthcare Global Enterprises Ltd. | 5.52% |
Divi's Laboratories Ltd. | 5.12% |
Abbott India Ltd. | 4.97% |
Cipla Ltd. | 4.77% |
Apollo Hospitals Enterprise Ltd. | 4.61% |
Rainbow Children's Medicare Ltd. | 4.42% |
Dr. Reddy's Laboratories Ltd. | 4.26% |
Glaxosmithkline Pharmaceuticals Ltd. | 4.12% |
Sun Pharmaceutical Industries Ltd. | 8.54% |
Ajanta Pharma Ltd. | 5.08% |
Divi's Laboratories Ltd. | 4.74% |
Gland Pharma Ltd. | 4.11% |
Caplin Point Laboratories Ltd. | 4.02% |
Lupin Ltd. | 3.77% |
Apollo Hospitals Enterprise Ltd. | 3.52% |
Alkem Laboratories Ltd. | 3.14% |
Dr. Reddy's Laboratories Ltd. | 3.01% |
Max Healthcare Institute Ltd. | 2.98% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Dec 2015
01 Aug 2005
